Product Description
| Cat Number | PI-020 |
|---|---|
| Category | Peptide |
| Pack Size | 10 mg |
| Description | Calpain and cathepsin B inhibitor |
| Modification | N terminal is carbobenzoxy, phenylalanine is terminal aldehyde |
| Purity | ‰¥95% (HPLC) |
| Biomarker Target | Calcium sensitive proteases |
| Sequence Three Letter Code | N-[N-[(Phenylmethoxy)carbonyl]-L-valyl]-phenylalaninal |
| Molecular Formula | C22H26N2O4 |
| Sl Sequence | Carbobenzoxy-VA-CHO |
| Solubility | Soluble in DMSO |
| Appearance | Freeze dried solid |
| Storage | Store desiccated, frozen and in the dark |
| References |
Li et al (1998) Postischemic treatment with a calpain inhibitor MDL 28170 ameliorates brain damage in a gerbil model of global ischemia. Neurosci.Lett. 247 17 PMID: 9637399Mehdi (1991) Cell-penetrating inhibitor of calpain. TiBS 16 150 PMID: 1877091Ai et al (2007) Calpain inhibitor MDL-28170 reduces the functional and structural deterioration of corpus callosum following fluid percussion injury. J.Neurotrauma 24 960 PMID: 17600513 Related areasAll peptides >All calcium sensitive protease modulators >All neuroscience research categories > |
| Note | The product is for research use only |
Share Item: